For 25 years, we have helped change what is possible in type 1 diabetes research.
Since 2001, TrialNet has brought together researchers, families, and participants in pursuit of a future without type 1 diabetes. New possibilities are now becoming reality through early detection, prevention research, newly diagnosed research, and the power of participation.
Get Screened
Screening is offered at no cost to eligible individuals to evaluate their personal risk of developing type 1 diabetes.
Get Screened
Join a Trial
Whether you're in the early stages of type 1 diabetes or newly diagnosed, we have trials to support your journey.
Join a Trial25 Years of Progress
Global Leadership
Longest-running international program for type 1 diabetes screening and prevention trials.
Screening Impact
TrialNet has screened more than 250,000 individuals at risk for T1D.
Disease Staging
Developed the widely adopted TrialNet ribbon explaining the stages and progression of T1D.
Therapy Research
Studied more than 10 disease-modifying therapies across multiple stages of progression.
FDA Breakthrough
TrialNet research helped lead to the first FDA-approved drug to delay type 1 diabetes.
Published Research
Published more than 300 peer-reviewed papers advancing T1D prevention and treatment.
ASPECTOS DESTACADOS DE TRIALNET
Comunícate con nosotros
- TrialNet para la Diabetes Tipo 1
- Teléfono: 1-800-425-8361
- Lunes a viernes, 12 pm a 8 pm, hora del Este
Enlaces rápidos
Buscar un centro
Más de 200 centros para detección del riesgo y realización de estudios en todo el mundo Buscar un centro
